- Global Pharma News & Resources

The Worldwide Cell Culture Media Market to 2026 - A $1.39 Billion Opportunity, Driven by the Rising Demand for Treating Chronic Diseases in a Customized Way -

The "Cell Culture Media Market; by Reagent Type; by Type; for Applications; and by End-users: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026" report has been added to's offering.

The global cell culture media was valued at around USD 676 million in the year 2017 and it is expected to reach approximately USD 1,394 million by 2026. The global cell culture media market is expected to exhibit a CAGR of more than 8.2% between 2018 and 2026.

The major factor driving the growth of cell culture media is the rising demand for treating chronic diseases in a customized way, which has increased the spending for cell culture development and is anticipated to drive the cell culture media market during the forecast period.

Moreover, raising awareness about stem cell culture and its advanced applications in large-scale life science industries will also fuel the growth of the market during the forecast period.

Also, the vast growth in biotechnology and pharmaceutical industrial activities worldwide and increasing spending in clinical research in developed as well as in developing economies is expected to drive the market during the forecast period.

However, to handle the cell culture process skilled personnel are required. Lack of skilled lab technicians and pharmacists in developing economies may limit the growth of the market.

Unskilled lab technicians and pharmacists are unable to understand the proper protocol and system for in vitro cultivation which can affect the cell culture and its growth, resulting in the contamination of cell culture media, issues of reproducibility, the occurrence of heavy trace elements, and others thus posing as a challenge for the market.

Topics Covered

1. Introduction

2. Executive Summary

3. Market Dynamics

4. Competitive Landscape

5. Reagent Type Segment Analysis

6. Type Segment Analysis

7. Application Segment Analysis

8. End-User Segment Analysis

9. Regional Segment Analysis

10. Company Profiles

  • Merck
  • BD Biosciences
  • Cell Essentials
  • Quality Biological
  • Bio-Techne Corporation (Atlanta Biologicals)
  • Affymetrix
  • SIAM Bioscience
  • Novozymes
  • Thermo Fisher Scientific
  • ClonTech Laboratories (Takara Bio USA)
  • Analytical Biological Services
  • J R Scientific
  • MP Biomedicals
  • SeraCare Life Sciences
  • Stemcell Technologies
  • Lonza
  • GE Healthcare

For more information about this report visit

View source version on

Editor Details

Last Updated: 30-Jan-2019